Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

AIMS: The risk of stroke in patients with atrial fibrillation (AF) increases with age. In the ARISTOTLE trial, apixaban when compared with warfarin reduced the rate of stroke, death, and bleeding. We evaluated these outcomes in relation to patient age. METHODS AND RESULTS: A total of 18 201 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Halvorsen, Sigrun, Atar, Dan, Yang, Hongqiu, De Caterina, Raffaele, Erol, Cetin, Garcia, David, Granger, Christopher B., Hanna, Michael, Held, Claes, Husted, Steen, Hylek, Elaine M., Jansky, Petr, Lopes, Renato D., Ruzyllo, Witold, Thomas, Laine, Wallentin, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104493/
https://www.ncbi.nlm.nih.gov/pubmed/24561548
http://dx.doi.org/10.1093/eurheartj/ehu046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104493/
https://www.ncbi.nlm.nih.gov/pubmed/24561548
http://dx.doi.org/10.1093/eurheartj/ehu046

Ejemplares similares